Abstracts

We invite you to share your endeavors with the healthcare community at the 2016 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation of America’s Clinical & Research Conference by submitting an abstract online. Submission deadline is September 13, 2016.

 

  • Increase Your Prestige. Seize the opportunity to present your work at one of the most highly regarded conferences in the field to over 2,400 attendees.
  • Gain added exposure for your work. Accepted abstracts will be published in the Inflammatory Bowel Diseases journal and scheduled for oral or poster presentation.
  • Share with your colleagues. Reception in conjunction with poster viewing encourages visibility.
  • Receive an award or grant. A limited number of travel grants will be offered to GI fellows-in-training and nurses to attend. These scholarship awards are available to assist with conference-related travel expenses by providing 1) free conference registration and 2) a scholarship of $500.

Participants interested in presenting data should submit abstracts online by September 13, 2016, 11:59PM ET. Abstracts are subject to acceptance by the Scientific Review Committee. Abstracts selected for presentation will be published in Inflammatory Bowel Diseases, February 2016 Supplement, and scheduled for oral or poster presentation. Only abstracts received by the submission deadline will be published. Acceptance notifications will be sent on October 17, 2016.

Abstracts will be accepted in the following categories: CLINICAL or PEDIATRIC or BASIC SCIENCE or NURSING. Please indicate which category is appropriate by checking the appropriate box in the online submission system.

Clinical Abstract Categories
C1. Investigator-initiated Controlled Clinical Trials
C2. Investigator-initiated Uncontrolled Clinical Trials
C3. Pharma-initiated Clinical Trials
C4. Procedures and Diagnostics
C5. Epidemiology and Outcomes Research
C6. Patient Care and Complications of Therapy
C7. Clinical Case Reports
C8. Surgery

Pediatric Clinical Abstract Categories
P1. Investigator-initiated Controlled Clinical Trials
P2. Investigator-initiated Uncontrolled Clinical Trials
P3. Pharma-initiated Clinical Trials
P4. Procedures and Diagnostics
P5. Epidemiology and Outcomes Research
P6. Patient Care and Complications of Therapy
P7. Clinical Case Reports
P8. Surgery

Basic Research Abstract Categories
B1. Genetics
B2. Microbiology
B3. Innate Immune System
B4. Adaptive Immune System
B5. Cytokines, Chemokines, and Cell Signaling
B6. Epithelial Cells
B7. Animal Models

Nursing Abstract Categories
N1. Clinical Education
N2. Clinical Basic Research
N3. Clinical Practice
N4. Other

Abstract Guidelines

Follow the online instructions
Accepted format:

  • Abstracts must be in English
  • 9 point Arial font
  • 500 word count limit
  • Use a concise title in title case only
  • List affiliations of author(s) as briefly as possible, with city, province and country
    • The system can accommodate up to 20 total authors
  • Use standard and well-accepted abbreviations
  • When listing references, use standard and well-accepted formats
  • Abstract content should be single-spaced and typed in lower case; abstract title should not include any formatting.
  • Abstracts shall be of original research and contain a concise statement of study aim.
  • Please include the following four (4) parts of your abstract:
    • Background, Methods, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable

 

Previous Presentation, Publication and Duplication of Abstracts:

  • Abstracts will not be considered for presentation if they have been or will be presented before the 2016 Advances in IBD Conference.
  • Abstracts will not be considered for presentation if they have been or will be published as an article (includes manuscripts accepted for publication) in either printed or electronic format upon the abstract submission deadline.
    Abstracts will not be considered for presentation if they have been duplicated in any way.
  • Abstracts may not be submitted to more than one category.
  • Abstracts that have been submitted to the Advances in IBD Conference in previous years, and have not been accepted for poster or oral presentation, are eligible for submission but must contain new, additional information to be considered.
  • Violations of these policies could result in a sanction from submitting abstracts to this conference for the submitting author.

Presentation Formats

  • Oral presentations
  • Poster presentations

Abstracts for oral or poster presentations will be chosen by the Scientific Review Committee.
Oral Abstract Presentation: Oral abstracts will be 10 minute presentations, which is the total allotted time. Therefore presenters must plan accordingly to schedule audience participation and questions. Employees of commercial interests are not preferred oral abstract presenters, but authors on the abstract who are not employees of commercial interests are eligible to present their data, if selected.

Poster Abstract Presentation: Poster presentations encourage interaction and exchange between authors and attendees. Detailed information regarding presentation times will be forthcoming.

Travel Grants

A limited number of travel grants will be offered to GI fellows-in-training and nurses to attend the 2016 Advances in Inflammatory Bowel Diseases Crohn’s & Colitis Foundation’s Clinical & Research Conference. These scholarship awards are available to assist with conference-related travel expenses by providing 1) free conference registration and 2) a scholarship of $500.

The first author must meet the following criteria to be considered for the award:

  • Candidate must submit a well-written, concise, and accurate abstract
  • Candidate must show original research of major importance in the field of medical/clinical Inflammatory Bowel Diseases conducted by themselves and co-investigators (if any)
  • Candidate must show relevance of the work to a current problem in patients involving Inflammatory Bowel Diseases
  • Candidate must be registered for the conference and present during the scheduled poster presentation times
  • For fellows-in-training, candidate for the award must be in training in a recognized GI training program. Candidate may be asked to provide a letter of support from his/her Program Director indicating their eligibility for the award. Candidate may be asked to provide a letter of support from his/her Program Director indicating their eligibility for the award


CCFA IBD Nurse & Advanced Practice Provider Travel Grant
 
Applicant Criteria:

  • Applicant must be a registered nurse, clinical nurse specialist, nurse practitioner, or physician assistant in any practice setting
  • Applicant must currently be involved in the area of IBD patient management
  • Graduate students in one of the above listed fields with an identified interest in the IBD patient population will be considered
  • Grant is open to nurses and advanced practice providers who have not previously received a travel grant for the AIBD conference

Essay submission guidelines:
Applicant must develop and submit an essay (500 word limit) on why attending the Advances in IBD Conference is important to you and the patients you manage. Please state the significance your participation in this conference will have on your practice, patient care or knowledge of IBD. Include how you will share your experience with others if applicable. Describe your current practice setting and specific questions you hope this conference will help answer or any ideas or projects that you hope to develop further as a result of this conference.
Additionally, you will be required to submit your curriculum vitae and describe the average number of IBD patients seen in your practice setting weekly (1-10, 10-20, >20 or “Do not see patients”).

Selection process:
Essays will be judged on the above criteria with an emphasis on why it is important for you to attend the AIBD Conference, including an explanation on significance to your practice and to IBD patient care, research or education.

Travel grant:
Awardees will receive a complimentary registration to the Advances in IBD Conference and a $500 stipend toward travel costs for attending the conference.

Commitment to Present

Submission of an abstract constitutes a commitment by the author(s) to present if it is accepted. Failure to present, if not justified, will jeopardize acceptance of future abstract submissions. Only the primary author or co-author may present the accepted abstract at the 2016 Advances in IBD Conference. This conference does not provide honoraria for abstract presenters.

The conference will withdraw abstracts upon written notification from the submitting author by October 31, 2016. If circumstances prevent attendance, the primary author must arrange for the presentation to be given by a co-author. Acceptance of the abstract obligates the author to present the paper.

Important Abstract Dates

Abstract Submission Deadline: September 13, 2016, 11:59PM ET
Abstract Notifications Mailed: October 17, 2016
Abstract Presenter Registration Deadline: November 17, 2016
Presentation Dates: December 8-10, 2016

Questions?

For questions, please contact the administrator by email at: ibdabstracts@imedex.com

 

Endorsed by

ACG

AGA

BSG

LASPGHAN

NASPGHAN